Skip to content

Insider · CIK 0001748786

Joseph Lind

other

Files at NHS (Neuberger High Yield Strategies Fund Inc.). First filing -, latest -.

In brief

Joseph Lind files SEC Form 4 as insider at NHS (Neuberger High Yield Strategies Fund Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Joseph Lind has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 15, 2026NHS
Neuberger High Yield Strategies Fund Inc.
XIn-the-money exercise
Common Stock
+12,833$6.50$83k45,333Apr 24, 2026
Apr 15, 2026NHS
Neuberger High Yield Strategies Fund Inc.
XIn-the-money exercise
Transferable Subscription Rights with Oversubscription Privderivative
-12,833--0Apr 24, 2026

Questions about Joseph Lind

Answered from the filings on this page, as of the latest one.

Is Joseph Lind buying or selling?

Joseph Lind has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Joseph Lind's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph Lind has 0.

Where does Joseph Lind file Form 4?

Joseph Lind has filed Form 4 at NHS (Neuberger High Yield Strategies Fund Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Joseph Lind: insider trades and track record | InsiderTell